Ash Team
April 3, 2024
•
5 min read
FIT screenings are a game-changer in colorectal cancer testing, offering reliability, convenience, and accuracy. As the healthcare industry continues to embrace remote health solutions, the integration of at-home FIT screenings meet HEDIS standards and revolutionize preventive care for patients who may not otherwise interact with healthcare. We delve into the realm of at-home health programs and explore how Ash is pioneering the integration of FIT screenings to bolster HEDIS compliance and improve patient outcomes.
At-home health testing programs are self-collection programs that enable patients to collect samples such as blood, stool, urine, or other materials and mail them to a laboratory for analysis. These programs can be initiated by healthcare providers or insurance plans to screen patients, while digital health companies may also offer the option to order kits through digital platforms or retail pharmacies.
At-home health testing programs help patients overcome various barriers to healthcare, including transportation challenges, difficulties in taking time off work, and child care obligations. They can be beneficial for patients in remote or rural areas with limited access to healthcare facilities who connect to essential support through telehealth. Some patients may also prefer the convenience and privacy of completing tests at home, potentially due to concerns about stigma or mistrust of medical providers.
The Colorectal Cancer Screening measure for HEDIS evaluates individuals aged 45–75 who receive appropriate screening through methods such as annual fecal occult blood tests, flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, computed tomography colonography every 5 years, or stool DNA tests every 3 years. Screening is crucial as it can detect colorectal cancer in its early stages, leading to a 90 percent survival rate after five years.
A FIT screening, short for fecal immunochemical test, is a type of fecal occult blood test and a method used to screen for colon cancer. It is a type of at-home self-collection screening that detects hidden blood in the stool, which can be an early sign of cancer. FIT is designed to specifically identify human blood from the lower intestines, minimizing interference from medications or dietary factors. Compared to other tests, FIT offers higher accuracy and produces fewer false positive results.
Chat with Ash about onboarding remote FIT screening to boost HEDIS.
While a colonoscopy is considered the gold standard for detecting and preventing colorectal cancer by detecting blood in the stool, FIT offers a less invasive alternative that helps overcome barriers to care such as privacy concerns. FIT is often used as an initial screening tool, especially for patients of average risk, with the potential to encourage more people to undergo screening.
Health plans can institute screening programs to target members aged 50–75 by mailing FIT kits. High kit return rates allow plans to complete the annual fecal occult blood test requirement for HEDIS. Higher HEDIS scores can lead to greater reimbursements and profit for health plans.
Health plans that partner with Ash can order white-labeled FIT kits to member homes and collect data through the Ash provider portal to achieve HEDIS compliance. In addition to FIT screening, Ash offers an extensive selection of 150+ laboratory tests tailored for clients seeking to initiate at-home health testing programs. We grant access to our nationally accredited CLIA/CAP certified laboratory network with a single integration. Through our white-label offerings, clients can uphold brand consistency for kits and digital platforms.
If you'd like to learn more about FIT screening or about our other solutions, feel free to contact us!